Takara Bio Europe AB – Trademark Portfolio
Entity Type: 16
Takara Bio Europe AB holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include CELLARTIS. The owner is based in Göteborg.
Arvid Wallgrens Backe 20
Göteborg SE-413 46 , SE
Showing of trademarks Trademarks
Trademark Classifications
Takara Bio Europe AB's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Takara Bio Europe AB have?
Takara Bio Europe AB has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending.
What trademark classes does Takara Bio Europe AB file in?
Takara Bio Europe AB files trademarks across 4 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Takara Bio Europe AB's most well-known trademarks?
Takara Bio Europe AB's registered trademark portfolio includes well-known marks such as CELLARTIS. These are among 1 currently registered trademark in the portfolio.
What is Takara Bio Europe AB's trademark registration success rate?
Takara Bio Europe AB has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 1 application is pending review.